These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 11034361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ, Chae CS, So JS, Tzartos SJ, Souroujon MC, Fuchs S, Im SH.
    Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
    [Abstract] [Full Text] [Related]

  • 3. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH, Barchan D, Maiti PK, Fuchs S, Souroujon MC.
    J Immunol; 2001 Jun 01; 166(11):6893-8. PubMed ID: 11359850
    [Abstract] [Full Text] [Related]

  • 4. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.
    Im SH, Barchan D, Maiti PK, Raveh L, Souroujon MC, Fuchs S.
    FASEB J; 2001 Oct 01; 15(12):2140-8. PubMed ID: 11641240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors.
    Souroujon MC, Maiti PK, Feferman T, Im SH, Raveh L, Fuchs S.
    Ann N Y Acad Sci; 2003 Sep 01; 998():533-6. PubMed ID: 14592924
    [Abstract] [Full Text] [Related]

  • 10. Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.
    Wang HB, Shi FD, Li H, Chambers BJ, Link H, Ljunggren HG.
    J Immunol; 2001 May 15; 166(10):6430-6. PubMed ID: 11342669
    [Abstract] [Full Text] [Related]

  • 11. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma.
    Li HL, Shi FD, Bai XF, Huang YM, van der Meide PH, Xiao BG, Link H.
    Clin Immunol Immunopathol; 1998 Apr 15; 87(1):15-22. PubMed ID: 9576006
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis.
    Im SH, Barchan D, Fuchs S, Souroujon MC.
    J Neuroimmunol; 2000 Nov 01; 111(1-2):161-8. PubMed ID: 11063834
    [Abstract] [Full Text] [Related]

  • 14. Protective molecular mimicry in experimental myasthenia gravis.
    Im SH, Barchan D, Feferman T, Raveh L, Souroujon MC, Fuchs S.
    J Neuroimmunol; 2002 May 01; 126(1-2):99-106. PubMed ID: 12020961
    [Abstract] [Full Text] [Related]

  • 15. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Link H, Ljungdahl A, Höjeberg B, Link J, He B, Qiao J, Melms A, Olsson T.
    Cell Immunol; 1994 Sep 01; 157(2):353-68. PubMed ID: 7520837
    [Abstract] [Full Text] [Related]

  • 16. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C, Goluszko E, Christadoss P.
    J Immunol; 2001 Mar 01; 166(5):3458-67. PubMed ID: 11207304
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment.
    Maiti PK, Feferman T, Im SH, Souroujon MC, Fuchs S.
    J Neuroimmunol; 2004 Jul 01; 152(1-2):112-20. PubMed ID: 15223243
    [Abstract] [Full Text] [Related]

  • 18. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW, Trinh VB, Gudipati E, Friend A, Page NA, Agius MA, Richman DP, Fairclough RH.
    Mol Immunol; 2014 Mar 01; 58(1):116-31. PubMed ID: 24333757
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
    Barchan D, Asher O, Tzartos SJ, Fuchs S, Souroujon MC.
    Eur J Immunol; 1998 Feb 01; 28(2):616-24. PubMed ID: 9521072
    [Abstract] [Full Text] [Related]

  • 20. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG, Zhang GX, Xiao BG, Wang ZY, Link J, Olsson T, Link H.
    Ann N Y Acad Sci; 1996 Feb 13; 778():273-87. PubMed ID: 8610980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.